Prophylactic single-dose prulifloxacin for catheter-associated urinary tract infection after tension-free vaginal tape procedure

[1]  F. Ghezzi,et al.  Tension-free vaginal tape for the treatment of urodynamic stress incontinence with intrinsic sphincteric deficiency , 2006, International Urogynecology Journal.

[2]  G. Prats,et al.  Prulifloxacin: a new antibacterial fluoroquinolone , 2006, Expert review of anti-infective therapy.

[3]  J. Car.  Urinary tract infections in women: diagnosis and management in primary care , 2006, BMJ : British Medical Journal.

[4]  A. Schito,et al.  Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa. , 2005, International journal of antimicrobial agents.

[5]  B. S. Niël-Weise,et al.  Antibiotic policies for short-term catheter bladder drainage in adults. , 2005, The Cochrane database of systematic reviews.

[6]  M. T. Rosignoli,et al.  Prulifloxacin versus Ciprofloxacin in the Treatment of Adults with Complicated Urinary Tract Infections , 2005, Urologia Internationalis.

[7]  F. Ghezzi,et al.  Influence of the type of anesthesia and hydrodissection on the complication rate after tension-free vaginal tape procedure. , 2005, European journal of obstetrics, gynecology, and reproductive biology.

[8]  M. Emberton,et al.  A pilot randomized double‐blind placebo‐controlled trial on the use of antibiotics on urinary catheter removal to reduce the rate of urinary tract infection: the pitfalls of ciprofloxacin , 2004, BJU international.

[9]  E. Lukacz,et al.  A randomized, double-blind, placebo-controlled comparison of the effect of nitrofurantoin monohydrate macrocrystals on the development of urinary tract infections after surgery for pelvic organ prolapse and/or stress urinary incontinence with suprapubic catheterization. , 2004, American journal of obstetrics and gynecology.

[10]  M. T. Rosignoli,et al.  Pharmacokinetics and Tolerability of Prulifloxacin after Single Oral Administration , 2003, Arzneimittelforschung.

[11]  K. Gupta.  Addressing antibiotic resistance. , 2003, Disease-a-month : DM.

[12]  M. Fall,et al.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. , 2002 .

[13]  E. Miró,et al.  In Vitro Activity of the Active Metabolite of Prulifloxacin (AF 3013) Compared with Six Other Fluoroquinolones , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[14]  K. Kreder,et al.  Complications of incontinence surgery , 1994, International Urogynecology Journal.

[15]  S. Mitsuhashi,et al.  Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone , 1993, Antimicrobial Agents and Chemotherapy.

[16]  H. Verbrugh,et al.  Prophylactic ciprofloxacin for catheter-associated urinary-tract infection , 1992, The Lancet.

[17]  T. Mountokalakis,et al.  Short-term versus prolonged systemic antibiotic prophylaxis in patients treated with indwelling catheters. , 1985, The Journal of urology.

[18]  R. Haley,et al.  The nationwide nosocomial infection rate. A new need for vital statistics. , 1985, American journal of epidemiology.

[19]  C. Kunin.  Genitourinary infections in the patient at risk: extrinsic risk factors. , 1984, The American journal of medicine.

[20]  B. Rosner,et al.  Mortality associated with nosocomial urinary-tract infection. , 1982, The New England journal of medicine.

[21]  M. Matera.  Pharmacologic characteristics of prulifloxacin. , 2006, Pulmonary pharmacology & therapeutics.

[22]  A. Weil,et al.  Who should care for anorectal dysfunction in women? , 2005, International Urogynecology Journal.

[23]  M. Fall,et al.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. , 2002, American journal of obstetrics and gynecology.

[24]  M. Fejgin,et al.  Prophylactic single-dose co-trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. , 1985, Chemotherapy.